MKI67 and neoplasm: Similarly, the administration of sunitinib, both alone and in combination with SLC-0111, significantly reduced tumor weight (Figure 1c) and inhibited cell proliferation, as shown by immunohistochemical staining for Ki67 (Figure S1), confirming the effect of drug exposure on tumor growth.